The White House revealed a set of measures on Thursday aimed at tackling the issues of artificial intelligence (AI) in response to concerns surrounding the new technology.
The White House regulations will affect how federal agencies purchase and use AI systems, potentially influencing the market for AI products and controlling how Americans interact with AI in various settings.
The National Science Foundation will spend $140 million on AI research and development, intending to apply AI to fields like public health, agriculture, and climate change.
According to CNN, the announcement coincides with a meeting between Vice President Kamala Harris and leading tech firms to discuss responsible AI research and a UK government inquiry into the pros and cons of AI.
President Joe Biden has previously stated that AI could help tackle climate change and diseases but also raised concerns over its potential negative impacts on national security and economic stability, per Time.
White House Faces Pressure To Regulate AI
The White House is under increased pressure to regulate AI and prevent its misuse due to the growing popularity of technologies like ChatGPT, which has been adopted by large IT corporations and startups, The New York Times reported.
The Biden administration listed a range of risks associated with the widespread use of AI tools, such as deep fakes, misinformation, job loss, biased algorithmic decision-making, physical risks posed by autonomous vehicles, and the threat of malicious hackers using AI.
The Biden administration released a proposal for an AI Bill of Rights last year, urging programmers to adhere to confidentiality, security, and equality as they build new AI capabilities.
The Commerce Department earlier this year produced optional AI risk management guidelines that they said could assist firms and organizations to "govern, map, measure, and manage" the possible risks at each stage of the development cycle.
The Department also asked for public opinion on AI regulatory measures in April, including audits and industry self-regulation.
Related Article: Researchers Develop Groundbreaking AI-Based Estimator for Pharmaceutical Manufacturing
